Cellebrite DI Ltd

Research Cellebrite DI Ltd (CLBT) on Bullrun: valuation model: 22.5% overvalued, market cap USD 3.54B, P/E 49.8. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCLBT
• ExchangeNASDAQ
• CountryIsrael
• SectorTechnology
• IndustrySoftware-Infrastructure
• CurrencyUSD
• Valuation signal22.5% overvalued
• Market capUSD 3.54B
• P/E49.8
• Financial periodFY2025
• RevenueUSD 475.68M
• Revenue growth18.6%
• Net incomeUSD 78.33M
• Free cash flowUSD 160.32M
• Gross margin84.2%

Valuation Snapshot

Bullrun's latest valuation model marks Cellebrite DI Ltd as 22.5% overvalued; latest market cap is USD 3.54B; P/E is 49.8.

About Cellebrite DI Ltd

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Frequently asked questions

Is Cellebrite DI Ltd overvalued or undervalued?

Bullrun's valuation model currently marks Cellebrite DI Ltd as 22.5% overvalued.

What is Cellebrite DI Ltd's market cap?

Cellebrite DI Ltd's market capitalization is USD 3.54B.

What is Cellebrite DI Ltd's P/E ratio?

Cellebrite DI Ltd's price-to-earnings (P/E) ratio is 49.8.

What does Cellebrite DI Ltd do?

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.